What is the share price of Transchem Ltd (TRANSCHEM) today?
The share price of TRANSCHEM as on 4th July 2025 is ₹40.90. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Transchem Ltd (TRANSCHEM) share?
The past returns of Transchem Ltd (TRANSCHEM) share are- Past 1 week: 4.65%
- Past 1 month: 3.34%
- Past 3 months: 17.09%
- Past 6 months: -16.53%
- Past 1 year: 9.18%
- Past 3 years: 106.05%
- Past 5 years: 289.15%
What are the peers or stocks similar to Transchem Ltd (TRANSCHEM)?
The peers or stocks similar to Transchem Ltd (TRANSCHEM) include:What is the market cap of Transchem Ltd (TRANSCHEM) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Transchem Ltd (TRANSCHEM) is ₹50.06 Cr as of 4th July 2025.What is the 52 week high and low of Transchem Ltd (TRANSCHEM) share?
The 52-week high of Transchem Ltd (TRANSCHEM) is ₹58 and the 52-week low is ₹31.10.What is the PE and PB ratio of Transchem Ltd (TRANSCHEM) stock?
The P/E (price-to-earnings) ratio of Transchem Ltd (TRANSCHEM) is 9.59. The P/B (price-to-book) ratio is 0.66.Which sector does Transchem Ltd (TRANSCHEM) belong to?
Transchem Ltd (TRANSCHEM) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Transchem Ltd (TRANSCHEM) shares?
You can directly buy Transchem Ltd (TRANSCHEM) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Transchem Ltd
TRANSCHEM Share Price
40.901.30% (-0.54)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
TRANSCHEM Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
AvgCan be considered moderately valued vs the market
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
TRANSCHEM Performance & Key Metrics
TRANSCHEM Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 9.55 | 0.66 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 37.15 | 6.59 | 0.81% |
TRANSCHEM Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
TRANSCHEM Company Profile
Transchem Ltd is the largest producer of a wide range of Anathematic API`s (Anti-Parasitic) in the world.They also offer specialized range of human use APIs.The company is one of the largest suppliers of Albendazole, Clorsulon, Diminazene Diaceturate, Toldimfos Sodium, Oxfendazole, Fenbendazole, Flubendazole, Mebendazole, Nitroxynil, Ramipril from India.
SUNPHARMA
PE Ratio
36.80
36.80
1Y Return
7.60%
7.60%
Buy Reco %
87.88
87.88
CIPLA
PE Ratio
23.18
23.18
1Y Return
2.20%
2.20%
Buy Reco %
73.33
73.33
TORNTPHARM
PE Ratio
59.65
59.65
1Y Return
17.34%
17.34%
Buy Reco %
70.83
70.83
DRREDDY
PE Ratio
19.24
19.24
1Y Return
0.89%
0.89%
Buy Reco %
55.17
55.17
ZYDUSLIFE
PE Ratio
22.26
22.26
1Y Return
11.97%
11.97%
Buy Reco %
44.44
44.44
TRANSCHEM Forecast
TRANSCHEM Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
TRANSCHEM
TRANSCHEM
Income
Balance Sheet
Cash Flow
Annual Normal View
TRANSCHEM Income Statement
TRANSCHEM Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1.78 | 2.11 | 2.93 | 2.76 | 26.83 | 6.66 | 4.24 | 7.81 | 11.16 | 11.17 | ||||||||||
Raw Materials | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.40 | 4.09 | 4.09 | ||||||||||
| Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.00 | 0.00 | 0.00 | ||||||||||||
| Employee Cost | 0.28 | 0.24 | 0.44 | 0.62 | 0.71 | 0.75 | 0.78 | 0.75 | ||||||||||||
| Selling & Administrative Expenses | 0.48 | 0.70 | 0.59 | 0.49 | 1.15 | 1.97 | 0.92 | 0.94 | ||||||||||||
| Operating & Other expenses | 0.22 | 0.75 | 0.32 | 0.27 | 0.06 | 0.02 | 0.03 | 0.06 | ||||||||||||
EBITDA | 0.79 | 0.42 | 1.58 | 1.37 | 24.89 | 3.92 | 2.51 | 5.66 | 7.07 | 7.08 | ||||||||||
| Depreciation/Amortization | 1.02 | 0.97 | 0.80 | 0.57 | 0.12 | 0.01 | 0.01 | 0.01 | 0.01 | — | ||||||||||
| PBIT | -0.23 | -0.55 | 0.78 | 0.80 | 24.77 | 3.91 | 2.50 | 5.65 | 7.06 | 7.08 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| PBT | -0.23 | -0.55 | 0.78 | 0.80 | 24.77 | 3.91 | 2.50 | 5.65 | 7.06 | 7.08 | ||||||||||
| Taxes & Other Items | 0.00 | 0.64 | 0.47 | 0.38 | 0.62 | 1.04 | 1.27 | 1.45 | 1.84 | 1.84 | ||||||||||
| Net Income | -0.23 | -1.19 | 0.31 | 0.42 | 24.15 | 2.87 | 1.23 | 4.20 | 5.22 | 5.24 | ||||||||||
| EPS | -0.19 | -0.97 | 0.25 | 0.34 | 19.73 | 2.34 | 1.00 | 3.43 | 4.27 | 4.28 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
TRANSCHEM Company Updates
TRANSCHEM Stock Peers
TRANSCHEM Past Performance & Peer Comparison
TRANSCHEM Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation-basic on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Transchem Ltd | 9.59 | 0.66 | — |
| Sun Pharmaceutical Industries Ltd | 36.80 | 5.99 | 0.95% |
| Cipla Ltd | 23.18 | 3.91 | 1.06% |
| Torrent Pharmaceuticals Ltd | 59.65 | 16.63 | 0.95% |
TRANSCHEM Stock Price Comparison
Compare TRANSCHEM with any stock or ETFCompare TRANSCHEM with any stock or ETF
TRANSCHEM
TRANSCHEM Holdings
TRANSCHEM Shareholdings
TRANSCHEM Promoter Holdings Trend
TRANSCHEM Promoter Holdings Trend
Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has increased by 4.77%
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
TRANSCHEM Institutional Holdings Trend
TRANSCHEM Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
TRANSCHEM Shareholding Pattern
TRANSCHEM Shareholding Pattern
TRANSCHEM Shareholding History
TRANSCHEM Shareholding History
Foreign Institutions
smallcases containing TRANSCHEM stock
smallcases containing TRANSCHEM stock
Looks like this stock is not in any smallcase yet.
TRANSCHEM Events
TRANSCHEM Events
TRANSCHEM Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
TRANSCHEM has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
TRANSCHEM Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
TRANSCHEM has not given any dividends in last 5 years
TRANSCHEM Dividends
TRANSCHEM Dividends
Hmm, looks like data is unavailable here. Please come back after some timeTRANSCHEM Stock News & Opinions
TRANSCHEM Stock News & Opinions
Articles & Videos
Corporate
Transchem to convene AGM
Transchem announced that the 48th Annual General Meeting(AGM) of the company will be held on 23 August 2025.Powered by Capital Market - Live
4 days agoCapital Market - Live
Earnings
Transchem standalone net profit declines 41.60% in the March 2025 quarter
Net profit of Transchem declined 41.60% to Rs 0.73 crore in the quarter ended March 2025 as against Rs 1.25 crore during the previous quarter ended March 2024. Sales rose 490.24% to Rs 2.42 crore in the quarter ended March 2025 as against Rs 0.41 crore during the previous quarter ended March 2024. For the full year,net profit rose 24.52% to Rs 5.23 crore in the year ended March 2025 as against Rs 4.20 crore during the previous year ended March 2024. Sales rose 541.46% to Rs 2.63 crore in the year ended March 2025 as against Rs 0.41 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales2.420.41 490 2.630.41 541 OPM %-19.83-109.76 --55.13-424.39 - PBDT1.081.71 -37 7.085.66 25 PBT1.081.71 -37 7.075.65 25 NP0.731.25 -42 5.234.20 25 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Transchem to announce Quarterly Result
Transchem will hold a meeting of the Board of Directors of the Company on 20 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Transchem standalone net profit rises 21.93% in the December 2024 quarter
Net profit of Transchem rose 21.93% to Rs 1.39 crore in the quarter ended December 2024 as against Rs 1.14 crore during the previous quarter ended December 2023. Sales reported to Rs 0.21 crore in the quarter ended December 2024. There were no Sales reported during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales0.210 0 OPM %-157.140 - PBDT1.861.53 22 PBT1.861.53 22 NP1.391.14 22 Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Transchem to announce Quarterly Result
Transchem will hold a meeting of the Board of Directors of the Company on 28 January 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Transchem standalone net profit rises 48.45% in the September 2024 quarter
Net profit of Transchem rose 48.45% to Rs 1.44 crore in the quarter ended September 2024 as against Rs 0.97 crore during the previous quarter ended September 2023. There were no Sales reported in the quarter ended September 2024 and during the previous quarter ended September 2023.Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Transchem to announce Quarterly Result
Transchem will hold a meeting of the Board of Directors of the Company on 15 October 2024.Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Transchem to hold AGM
Transchem announced that the Annual General Meeting (AGM) of the company will be held on 24 August 2024.Powered by Capital Market - Live
11 months agoCapital Market - Live
Earnings
Transchem standalone net profit rises 95.29% in the June 2024 quarter
Net profit of Transchem rose 95.29% to Rs 1.66 crore in the quarter ended June 2024 as against Rs 0.85 crore during the previous quarter ended June 2023. There were no Sales reported in the quarter ended June 2024 and during the previous quarter ended June 2023.Powered by Capital Market - Live
11 months agoCapital Market - Live
BRIEF-Transchem Ltd Disposes Undertaking For 260 Mln Rupees - Investing.com India
5 years agoInvesting.com
Over the last 5 years, revenue has grown at a yearly rate of 32.24%, vs industry avg of 10.14%
Over the last 5 years, market share stayed at 0%
Over the last 5 years, net income has grown at a yearly rate of 65.53%, vs industry avg of 20.01%